FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2595767897> ?p ?o ?g. }

• W2595767897 endingPage "947" @default.
• W2595767897 startingPage "940" @default.
• W2595767897 abstract "Summary Diabetes increases cardiovascular risk and reduces pharmacodynamic response to some oral antiplatelet drugs. This study aimed to determine whether ticagrelor 60 mg twice daily (bid) provided potent and consistent platelet inhibition in patients with vs without diabetes in the PEGASUS-TIMI 54 platelet function substudy. Out of 180 patients studied, 58 patients were randomised to and had received at least four weeks of ticagrelor 60 mg bid, with 20 (34 %) having diabetes, 58 patients received ticagrelor 90 mg bid, with 12 (21 %) having diabetes, and 64 patients received placebo, with 18 (28 %) having diabetes. Blood was sampled pre- and 2 hours post-maintenance dose. In patients treated with ticagrelor 60 mg bid, on-treatment platelet reactivity to ADP, as determined by light transmission aggregometry (LTA), VerifyNow and VASP, was similar in patients with vs without diabetes (LTA post-dose, ADP 20 ?M: 29 ± 14 vs 34 ± 10 %, respectively; p = 0.19). A consistent inhibitory effect of ticagrelor 60 mg bid was observed pre- and post-dose regardless of diabetes status, even in insulin-treated patients. Patients with diabetes did not have an increased incidence of high platelet reactivity in either ticagrelor group. Platelet reactivity was similar in patients with diabetes treated with ticagrelor 60 mg vs 90 mg bid. Pharmacokinetics of ticagrelor were not affected by diabetes status. In conclusion, ticagrelor 60 mg bid is equally effective at reducing platelet reactivity in patients with and without diabetes, yielding a consistently high level of platelet inhibition regardless of diabetes status." @default.
• W2595767897 created "2017-03-23" @default.
• W2595767897 creator A5003831287 @default.
• W2595767897 creator A5010038546 @default.
• W2595767897 creator A5024294469 @default.
• W2595767897 creator A5026004870 @default.
• W2595767897 creator A5028730426 @default.
• W2595767897 creator A5030057930 @default.
• W2595767897 creator A5039450208 @default.
• W2595767897 creator A5040418600 @default.
• W2595767897 creator A5043982558 @default.
• W2595767897 creator A5050774463 @default.
• W2595767897 creator A5051638272 @default.
• W2595767897 creator A5052994249 @default.
• W2595767897 creator A5060898801 @default.
• W2595767897 creator A5086223086 @default.
• W2595767897 creator A5090903599 @default.
• W2595767897 date "2017-01-01" @default.
• W2595767897 modified "2023-09-27" @default.
• W2595767897 title "Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status" @default.
• W2595767897 cites W1137380392 @default.
• W2595767897 cites W136622145 @default.
• W2595767897 cites W175512219 @default.
• W2595767897 cites W1964067479 @default.
• W2595767897 cites W1978948125 @default.
• W2595767897 cites W1986266381 @default.
• W2595767897 cites W1990018236 @default.
• W2595767897 cites W2004836002 @default.
• W2595767897 cites W2005675487 @default.
• W2595767897 cites W2019661749 @default.
• W2595767897 cites W2036428755 @default.
• W2595767897 cites W2039182832 @default.
• W2595767897 cites W2041872039 @default.
• W2595767897 cites W2070200806 @default.
• W2595767897 cites W2084276985 @default.
• W2595767897 cites W2099022345 @default.
• W2595767897 cites W2120101441 @default.
• W2595767897 cites W2127395662 @default.
• W2595767897 cites W2127984785 @default.
• W2595767897 cites W2135319342 @default.
• W2595767897 cites W2141358924 @default.
• W2595767897 cites W2161043271 @default.
• W2595767897 cites W2166196321 @default.
• W2595767897 cites W2167678178 @default.
• W2595767897 cites W2298958687 @default.
• W2595767897 cites W2304235240 @default.
• W2595767897 cites W2345294515 @default.
• W2595767897 cites W2412782592 @default.
• W2595767897 cites W2510902864 @default.
• W2595767897 doi "https://doi.org/10.1160/th16-09-0703" @default.
• W2595767897 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28300867" @default.
• W2595767897 hasPublicationYear "2017" @default.
• W2595767897 type Work @default.
• W2595767897 sameAs 2595767897 @default.
• W2595767897 citedByCount "19" @default.
• W2595767897 countsByYear W25957678972017 @default.
• W2595767897 countsByYear W25957678972018 @default.
• W2595767897 countsByYear W25957678972019 @default.
• W2595767897 countsByYear W25957678972020 @default.
• W2595767897 countsByYear W25957678972021 @default.
• W2595767897 countsByYear W25957678972022 @default.
• W2595767897 crossrefType "journal-article" @default.
• W2595767897 hasAuthorship W2595767897A5003831287 @default.
• W2595767897 hasAuthorship W2595767897A5010038546 @default.
• W2595767897 hasAuthorship W2595767897A5024294469 @default.
• W2595767897 hasAuthorship W2595767897A5026004870 @default.
• W2595767897 hasAuthorship W2595767897A5028730426 @default.
• W2595767897 hasAuthorship W2595767897A5030057930 @default.
• W2595767897 hasAuthorship W2595767897A5039450208 @default.
• W2595767897 hasAuthorship W2595767897A5040418600 @default.
• W2595767897 hasAuthorship W2595767897A5043982558 @default.
• W2595767897 hasAuthorship W2595767897A5050774463 @default.
• W2595767897 hasAuthorship W2595767897A5051638272 @default.
• W2595767897 hasAuthorship W2595767897A5052994249 @default.
• W2595767897 hasAuthorship W2595767897A5060898801 @default.
• W2595767897 hasAuthorship W2595767897A5086223086 @default.
• W2595767897 hasAuthorship W2595767897A5090903599 @default.
• W2595767897 hasBestOaLocation W25957678972 @default.
• W2595767897 hasConcept C111113717 @default.
• W2595767897 hasConcept C112705442 @default.
• W2595767897 hasConcept C126322002 @default.
• W2595767897 hasConcept C134018914 @default.
• W2595767897 hasConcept C164705383 @default.
• W2595767897 hasConcept C2777628954 @default.
• W2595767897 hasConcept C2777698277 @default.
• W2595767897 hasConcept C2777995511 @default.
• W2595767897 hasConcept C2780400711 @default.
• W2595767897 hasConcept C2780890252 @default.
• W2595767897 hasConcept C500558357 @default.
• W2595767897 hasConcept C555293320 @default.
• W2595767897 hasConcept C71924100 @default.
• W2595767897 hasConcept C89560881 @default.
• W2595767897 hasConcept C98274493 @default.
• W2595767897 hasConceptScore W2595767897C111113717 @default.
• W2595767897 hasConceptScore W2595767897C112705442 @default.
• W2595767897 hasConceptScore W2595767897C126322002 @default.
• W2595767897 hasConceptScore W2595767897C134018914 @default.
• W2595767897 hasConceptScore W2595767897C164705383 @default.

• next